UnitedHealth Group Incorporated
UNH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.07 | -0.46 | 1.23 | -2.39 |
| FCF Yield | 1.61% | 2.22% | 0.95% | 0.31% |
| EV / EBITDA | 68.74 | 54.01 | 52.27 | 58.92 |
| Quality | ||||
| ROIC | 1.64% | 2.21% | 3.53% | 3.33% |
| Gross Margin | 18.24% | 17.93% | 21.70% | 21.14% |
| Cash Conversion Ratio | 2.34 | 2.01 | 0.84 | 0.43 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.53% | 6.65% | 6.87% | 7.28% |
| Free Cash Flow Growth | -19.79% | 38.26% | 212.83% | -88.75% |
| Safety | ||||
| Net Debt / EBITDA | 9.93 | 8.17 | 4.97 | 5.84 |
| Interest Coverage | 4.30 | 5.01 | 9.14 | 7.75 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -30.05 | -28.97 | -30.66 | -34.36 |